Axi-cel proves effective as first-line treatment for high-risk lymphoma
Results from the ZUMA-12 trial led by researchers at The University of Texas MD Anderson Cancer…
Results from the ZUMA-12 trial led by researchers at The University of Texas MD Anderson Cancer…
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large…